Wan Ip

1.6k total citations
33 papers, 986 citations indexed

About

Wan Ip is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Wan Ip has authored 33 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 10 papers in Genetics and 7 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Wan Ip's work include Neonatal Respiratory Health Research (11 papers), Cystic Fibrosis Research Advances (11 papers) and Blood disorders and treatments (8 papers). Wan Ip is often cited by papers focused on Neonatal Respiratory Health Research (11 papers), Cystic Fibrosis Research Advances (11 papers) and Blood disorders and treatments (8 papers). Wan Ip collaborates with scholars based in Canada, United States and Netherlands. Wan Ip's co-authors include Peter R. Durie, Tanja Gonska, Johanna M. Rommens, Michael V. Sefton, Lynda Ellis, Mary Corey, Jodi Morrison, Christine E. Bear, Hedy Ginzberg and Annie Dupuis and has published in prestigious journals such as Biomaterials, American Journal of Respiratory and Critical Care Medicine and Diabetes.

In The Last Decade

Wan Ip

33 papers receiving 972 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wan Ip Canada 17 461 287 224 139 136 33 986
Susumu Kanzaki Japan 21 103 0.2× 339 1.2× 57 0.3× 158 1.1× 107 0.8× 75 1.2k
Jayaraman Lakshmanan United States 12 143 0.3× 115 0.4× 50 0.2× 124 0.9× 61 0.4× 16 794
Jing Sun China 18 113 0.2× 103 0.4× 89 0.4× 252 1.8× 73 0.5× 95 1.1k
Avani Desai United States 10 100 0.2× 36 0.1× 298 1.3× 95 0.7× 147 1.1× 10 1.2k
Shervin R. Dashti United States 25 206 0.4× 33 0.1× 77 0.3× 200 1.4× 234 1.7× 40 1.6k
Xiaojing Liu China 13 121 0.3× 45 0.2× 122 0.5× 61 0.4× 68 0.5× 44 794
Horng‐Der Tsai Taiwan 20 70 0.2× 110 0.4× 148 0.7× 119 0.9× 55 0.4× 60 1.2k
Takayuki Okada Japan 16 96 0.2× 30 0.1× 156 0.7× 123 0.9× 65 0.5× 69 782
Sukanya Subramanian United States 14 89 0.2× 94 0.3× 64 0.3× 162 1.2× 43 0.3× 23 950

Countries citing papers authored by Wan Ip

Since Specialization
Citations

This map shows the geographic impact of Wan Ip's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Ip with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Ip more than expected).

Fields of papers citing papers by Wan Ip

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Ip. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Ip. The network helps show where Wan Ip may publish in the future.

Co-authorship network of co-authors of Wan Ip

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Ip. A scholar is included among the top collaborators of Wan Ip based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Ip. Wan Ip is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ip, Wan, Claire Bartlett, Julie Avolio, et al.. (2023). Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis. Life Science Alliance. 6(6). e202201857–e202201857. 8 indexed citations
3.
Ahmadi, Saumel, Mingyuan Li, Wan Ip, et al.. (2019). Augmentation of Cystic Fibrosis Transmembrane Conductance Regulator Function in Human Bronchial Epithelial Cells via SLC6A14-Dependent Amino Acid Uptake. Implications for Treatment of Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 61(6). 755–764. 9 indexed citations
4.
Li, Bo, Carol Lee, Alison Hock, et al.. (2017). Inhibition of corticotropin-releasing hormone receptor 1 and activation of receptor 2 protect against colonic injury and promote epithelium repair. Scientific Reports. 7(1). 46616–46616. 48 indexed citations
5.
Ahmadi, Saumel, Zoltán Bozóky, Michelle Di Paola, et al.. (2017). Phenotypic profiling of CFTR modulators in patient-derived respiratory epithelia. npj Genomic Medicine. 2(1). 12–12. 57 indexed citations
6.
Li, Bo, Augusto Zani, Carol Lee, et al.. (2016). Endoplasmic reticulum stress is involved in the colonic epithelium damage induced by maternal separation. Journal of Pediatric Surgery. 51(6). 1001–1004. 21 indexed citations
7.
Cao, Huibi, Hong Ouyang, Wan Ip, et al.. (2015). Testing gene therapy vectors in human primary nasal epithelial cultures. Molecular Therapy — Methods & Clinical Development. 2. 15034–15034. 15 indexed citations
8.
Eckford, Paul D. W., Mohabir Ramjeesingh, Steven V. Molinski, et al.. (2014). VX-809 and Related Corrector Compounds Exhibit Secondary Activity Stabilizing Active F508del-CFTR after Its Partial Rescue to the Cell Surface. Chemistry & Biology. 21(5). 666–678. 78 indexed citations
9.
Carvalho, Claudia M.B., Luciana W. Zuccherato, Christopher L. Williams, et al.. (2014). Structural variation and missense mutation in SBDSassociated with Shwachman-Diamond syndrome. BMC Medical Genetics. 15(1). 64–64. 6 indexed citations
10.
Quinton, Paul, Wan Ip, Annie Dupuis, et al.. (2012). β-Adrenergic Sweat Secretion as a Diagnostic Test for Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(8). 732–739. 76 indexed citations
11.
Bissonnette, Robert, Yves Poulin, Yabo Zhou, et al.. (2011). Efficacy and safety of topical WBI-1001 in patients with mild to severe atopic dermatitis: results from a 12-week, multicentre, randomized, placebo-controlled double-blind trial. British Journal of Dermatology. 166(4). 853–860. 70 indexed citations
12.
Stormon, Michael, Wan Ip, Lynda Ellis, et al.. (2010). Evidence of a Generalized Defect of Acinar Cell Function in Shwachman‐Diamond Syndrome. Journal of Pediatric Gastroenterology and Nutrition. 51(1). 8–13. 8 indexed citations
13.
Toiviainen‐Salo, Sanna, Peter R. Durie, Wan Ip, et al.. (2008). Magnetic Resonance Imaging Findings of the Pancreas in Patients with Shwachman-Diamond Syndrome and Mutations in the SBDS Gene. The Journal of Pediatrics. 152(3). 434–436.e2. 20 indexed citations
14.
Ip, Wan, Lynda Ellis, Satti Beharry, et al.. (1999). SERUM PANCREATIC ENZYMES IN PATIENTS WITH SHWACHMAN‐DIAMOND SYNDROME. Journal of Pediatric Gastroenterology and Nutrition. 29(4). 504–504. 2 indexed citations
15.
Ginzberg, Hedy, Lynda Ellis, Jodi Morrison, et al.. (1999). Shwachman syndrome: Phenotypic manifestations of sibling sets and isolated cases in a large patient cohort are similar. The Journal of Pediatrics. 135(1). 81–88. 165 indexed citations
16.
Ip, Wan, Satti Beharry, & Peter R. Durie. (1998). Impact of Protein Deprivation on Protein and DNA Synthesis in the Developing Rat Pancreas. Neonatology. 74(4). 294–303. 1 indexed citations
17.
Wilson, David C., Lynda Ellis, Julian Zielenski, et al.. (1998). Uncertainty in the diagnosis of cystic fibrosis: Possible role of in vivo nasal potential difference measurements. The Journal of Pediatrics. 132(4). 596–599. 46 indexed citations
18.
Ip, Wan & Michael V. Sefton. (1991). Platelet consumption by NHLBI reference materials and Silastic. Journal of Biomedical Materials Research. 25(10). 1321–1324. 8 indexed citations
19.
Ip, Wan & Michael V. Sefton. (1991). Platelet consumption by polyvinyl alcohol coated tubing in canines. Journal of Biomedical Materials Research. 25(7). 875–887. 23 indexed citations
20.
Sefton, Michael V., et al.. (1984). THE THROMBORESISTANCE OF A HEPARIN-POLYVINYL ALCOHOL HYDROGEL†. Chemical Engineering Communications. 30(3-5). 141–154. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026